Insider Cluster (2 insiders) ·Filed Apr 9, 2026
Insider cluster: 2 insiders, $573K total
Actionable Insight • Neutral
The sales are minor relative to company size and likely part of pre-arranged trading plans. No immediate concern for traders, but continued monitoring of insider activity is warranted if volume increases.
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▼ -4.75% at T+60d
NEUTRAL call ✗ call lost -4.75% · α vs SPY -15.24% · entry $574.52 → $547.25
T+1d
-0.56%
call -0.56% · α -0.50%
$571.32
settled 6mo ago
T+5d
+0.49%
call +0.49% · α -2.70%
$577.33
settled 6mo ago
T+20d
+3.87%
call +3.87% · α -3.70%
$596.76
settled 5mo ago
T+60d
-4.75%
call -4.75% · α -15.24%
$547.25
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
CEO Martine Rothblatt and CFO James Edgemond each conducted open-market share sales totaling $573K in the past week, following routine derivative exercises. The sales represent a small fraction of their overall holdings and appear aligned with pre-scheduled 10b5-1 plans or tax-related planning.
Key Financial Metrics
Direction
selling
Total Value
$573.0K
Insiders
2
Key Facts
- CEO Martine Rothblatt sold 442 shares for $251K on 2026-04-10 and additional shares totaling $724K earlier in the week, alongside multiple non-cash derivative exercises.
- CFO James Edgemond sold 560 shares for $322K on 2026-04-09, following a derivative exercise of 10,000 shares.
- Total open-market sales by insiders in the cluster: $573K over 7 days.
- Market cap of UTHR is $25.1B; total sales represent 0.0023% of market cap — well below materiality threshold.
- Derivative exercises (M-coded transactions) are non-cash events and do not reflect economic selling pressure.
Financial Impact
$573,000 in open-market sales
insider ownershipshares outstanding (no change)
Risk Factors
- Perception risk if media mischaracterizes routine derivative exercises as insider selling.
- Potential for negative sentiment if future filings show accelerating sell-side activity by C-suite executives.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1776112363209 |
91 reports for UTHR
80% Hit rate best @ T+60▲ +5.53%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Showing 10 of 91
US Market Status
Market Open — Closes in 6h 27m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access